TLX.AX
Telix Pharmaceuticals Limited
ASXAUDEQUITY
DELAYED
Last price
15.62
▼ 1.76 (10.13%)
MARKET · —
Price
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
16.68
Prev close
17.38
Day high
16.76
Day low
15.62
Volume
4.58M
Market cap
—
P/E (TTM)
—
52W range
8.26 – 19.07
Trailing performance
Returnvs SPY
1W
-6.63%
-5.3%
1M
+2.97%
-0.8%
3M
+16.31%
+13.2%
6M
+62.54%
+51.5%
YTD
+39.46%
+27.2%
1Y
-16.74%
-36.7%
3Y
+47.22%
-27.0%
5Y
+126.71%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Free account
3 more panels on TLX.AX open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $803.79M | $516.55M | $332.98M | $108.91M | — | +55.6% |
| Operating revenue | $803.79M | $516.55M | $332.98M | $108.91M | — | +55.6% |
| Cost of revenue | $377.36M | $180.39M | $123.44M | $44.34M | — | +109.2% |
| Gross profit | $426.44M | $336.16M | $209.53M | $64.58M | — | +26.9% |
| Research & development | $171.25M | $127.93M | $85.31M | $54.89M | — | +33.9% |
| Selling, general & admin | $237.15M | $152.19M | $89.38M | $59.47M | — | +55.8% |
| Total operating expense | $408.38M | $280.58M | $174.57M | $115.05M | — | +45.6% |
| Operating income | $18.05M | $55.58M | $34.97M | -$50.48M | — | -67.5% |
| Net interest income | -$35.04M | -$17.26M | -$8.41M | -$4.55M | — | -103.0% |
| Pre-tax income | -$5.27M | $37.91M | $2.59M | -$98.62M | — | -113.9% |
| Tax provision | $1.86M | $4.23M | -$1.61M | $5.46M | — | -56.1% |
| Net income | -$7.13M | $33.69M | $4.21M | -$104.08M | — | -121.2% |
| Net income to common | -$7.13M | $33.69M | $4.21M | -$104.08M | — | -121.2% |
| Basic EPS | -0.02 | 0.10 | 0.01 | -0.34 | — | -120.7% |
| Diluted EPS | -0.02 | 0.10 | 0.01 | -0.23 | — | -121.6% |
| EBIT | $35.15M | $62.06M | $11.54M | -$62.60M | — | -43.4% |
| EBITDA | $35.15M | $62.06M | $11.54M | -$62.60M | — | -43.4% |
| Basic shares | 319.18M | 331.23M | 319.18M | 310.64M | — | -3.6% |
| Diluted shares | 323.71M | — | 319.18M | 310.64M | 282.21M | — |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $141.87M | $440.00M | $84.30M | $116.33M | — | -67.8% |
| Cash & short-term investments | $141.87M | $440.00M | $84.30M | $116.33M | — | -67.8% |
| Accounts receivable | $129.20M | $86.93M | $44.04M | $39.35M | — | +48.6% |
| Inventory | $37.08M | $23.62M | $12.74M | $8.48M | — | +57.0% |
| Total current assets | $330.28M | $570.12M | $158.69M | $173.23M | — | -42.1% |
| Property, plant & equipment | $115.61M | $33.65M | $20.86M | $18.84M | — | +243.6% |
| Goodwill & intangibles | $592.82M | $257.86M | $75.05M | $58.98M | — | +129.9% |
| Total assets | $1.16B | $940.38M | $277.26M | $173.72M | — | +23.8% |
| Total current liabilities | $231.62M | $205.09M | $111.37M | $58.20M | — | +12.9% |
| Current debt | $13.11M | $11.76M | $660.00K | — | $13.77K | +11.5% |
| Long-term debt | $391.91M | $341.81M | $5.95M | $2.25M | — | +14.7% |
| Total debt | $467.11M | $360.16M | $12.26M | $10.45M | — | +29.7% |
| Total liabilities | $748.61M | $587.44M | $174.61M | $175.35M | — | +27.4% |
| Retained earnings | -$154.54M | -$152.91M | -$187.12M | -$272.81M | — | -1.1% |
| Shareholder equity | $415.38M | $352.94M | $102.64M | $54.43M | — | +17.7% |
| Working capital | $98.66M | $365.03M | $47.32M | $87.68M | — | -73.0% |
| Net tangible assets | -$177.45M | $95.08M | $27.59M | $14.30M | — | -286.6% |
| Shares issued | 338.78M | 334.72M | 323.73M | 316.34M | — | +1.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Capital expenditure | -$43.78M | -$22.18M | -$7.11M | -$9.43M | -97.3% |
| Investing cash flow | -$285.92M | -$86.69M | -$16.84M | -$17.00M | -229.8% |
| Share buybacks | — | — | — | -$7.82M | — |
| Financing cash flow | -$3.72M | $416.79M | $7.09M | $119.03M | -100.9% |
| Free cash flow | -$61.07M | $5.31M | $7.16M | -$77.83M | -1,250.9% |
| End cash position | $141.87M | $440.00M | $84.30M | $79.14M | -67.8% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
| Line item | 2025-12-31 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $141.87M | $207.16M | $440.00M | -31.5% |
| Cash & short-term investments | $141.87M | $207.16M | $440.00M | -31.5% |
| Accounts receivable | $129.20M | — | $86.93M | — |
| Inventory | $37.08M | — | $23.62M | — |
| Total current assets | $330.28M | — | $570.12M | — |
| Property, plant & equipment | $115.61M | — | $33.65M | — |
| Goodwill & intangibles | $592.82M | — | $257.86M | — |
| Total assets | $1.16B | — | $940.38M | — |
| Total current liabilities | $231.62M | $298.58M | $205.09M | -22.4% |
| Current debt | $13.11M | $12.69M | $11.76M | +3.3% |
| Long-term debt | $391.91M | — | $341.81M | — |
| Total debt | $467.11M | — | $360.16M | — |
| Total liabilities | $748.61M | $768.01M | $587.44M | -2.5% |
| Retained earnings | -$154.54M | -$150.98M | -$152.91M | -2.4% |
| Shareholder equity | $415.38M | $421.94M | $352.94M | -1.6% |
| Working capital | $98.66M | — | $365.03M | — |
| Net tangible assets | -$177.45M | -$162.23M | $95.08M | -9.4% |
| Shares issued | 338.78M | 334.72M | 334.72M | +1.2% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
16.76
-6.80% from price
SMA 20
15.69
-0.44% from price
SMA 50
15.62
-0.03% from price
SMA 100
14.91
+4.79% from price
SMA 200
13.43
+16.29% from price
EMA 12
16.35
-4.46% from price
EMA 26
15.94
-2.03% from price
EMA 50
15.51
+0.73% from price
RSI (14)
47.4
Neutral
MACD (12,26,9)
0.41
Hist 0.05
ATR (14)
0.79
5.08% of price
Realised vol 30D
51.0%
Annualised
Bollinger upper
18.08
20, 2σ
Bollinger lower
13.30
20, 2σ
50 / 200 cross
Golden
15.62 vs 13.43
Trend bias
Above 200
+16.29%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.53
Less volatile than market
Correlation to SPY
0.12
Largely independent
Realised vol 30D
51.0%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-54.4%
Peak to trough
Max drawdown 5Y
-72.3%
Peak to trough
ATR 14
0.79
5.08% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
South Korean survivor fights for workplace harassment 'justice'
AFP · 12m ago
Messi scores but Miami slump continues with loss to Toronto
AFP · 13m ago
Josh Johnson's best plays from 2-TD game vs. Bears Preseason Week 2
NFL Highlights · 18m ago
Sydney marathon unveils medal with wrong stadium
AFP · 23m ago
Prince Harry: royal misfit making unlikely UK return
AFP · 24m ago
Sandisk (SNDK) Stock Sees Fair Value Lift After Investor Day And Earnings
Simply Wall St. · 27m ago
Alaska Air Group (ALK) Following CEO Buying And New Routes Has Value Back In Focus
Simply Wall St. · 27m ago
iQIYI (IQ) Could Be 31% Undervalued Following Weak Earnings
Simply Wall St. · 27m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.